Twinbeech Capital »

United Therapeutics Corporation shares owned by Twinbeech Capital

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Twinbeech Capital from 13F filings

Historical chart of Twinbeech Capital investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Twinbeech Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Twinbeech Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $16M 70k 219.89
2023-09-30 $621k 2.7k 225.87
2021-09-30 $4.0M 22k 184.57
2019-12-31 $369k 4.2k 87.96

More positions owned by Twinbeech Capital

Lowe's Companies (LOW)
Home Depot (HD)
Meta Platforms Cl A (META)
Nike CL B (NKE)
Sherwin-Williams Company (SHW)
Apple (AAPL)
Lauder Estee Cos Cl A (EL)
Palantir Technologies Cl A (PLTR)
Accenture Plc Ireland Shs Class A (ACN)
CSX Corporation (CSX)
S&p Global (SPGI)
ON Semiconductor (ON)
Atlassian Corporation Cl A (TEAM)
Las Vegas Sands (LVS)
L3harris Technologies (LHX)

View all positions for Twinbeech Capital

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
FMR
AQR Capital Management
Geode Capital Management
Citadel Advisors
Citigroup
Henderson Group
Hanna Zanoni
Dimensional Fund Advisors
Morgan Stanley
LSV Asset Management
Pacer Advisors

View all funds holding United Therapeutics Corporation